Display options
Cite
Waters DD, Hsue PY. PCSK9 Inhibition to Lower LDL-Cholesterol and Reduce Cardiovascular Risk: Great Expectations. Circ Res. 2015;116(10):1643-5doi: 10.1161/CIRCRESAHA.115.306493.
Waters, D. D., & Hsue, P. Y. (2015). PCSK9 Inhibition to Lower LDL-Cholesterol and Reduce Cardiovascular Risk: Great Expectations. Circulation research, 116(10), 1643-5. https://doi.org/10.1161/CIRCRESAHA.115.306493
Waters, David D, and Hsue, Priscilla Y. "PCSK9 Inhibition to Lower LDL-Cholesterol and Reduce Cardiovascular Risk: Great Expectations." Circulation research vol. 116,10 (2015): 1643-5. doi: https://doi.org/10.1161/CIRCRESAHA.115.306493
Waters DD, Hsue PY. PCSK9 Inhibition to Lower LDL-Cholesterol and Reduce Cardiovascular Risk: Great Expectations. Circ Res. 2015 May 08;116(10):1643-5. doi: 10.1161/CIRCRESAHA.115.306493. PMID: 25953922.
Copy Download .nbib Format: NLM
Share it on

Circ Res. 2015 May 08;116(10):1643-5. doi: 10.1161/CIRCRESAHA.115.306493.

PCSK9 Inhibition to Lower LDL-Cholesterol and Reduce Cardiovascular Risk: Great Expectations.

Circulation research

David D Waters, Priscilla Y Hsue

Affiliations

  1. From the Division of Cardiology, San Francisco General Hospital, and the Department of Medicine, University of California, San Francisco. [email protected].
  2. From the Division of Cardiology, San Francisco General Hospital, and the Department of Medicine, University of California, San Francisco.

PMID: 25953922 DOI: 10.1161/CIRCRESAHA.115.306493

[No abstract available.]

Publication Types